Cesca Therapeutics (KOOL) Expands CAR-TXpress IP Portfolio with Filing of New Patent Covering Cell Activation & Transduction
Tweet Send to a Friend
Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
